LMR Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9M Buy
1,335,436
+170,078
+15% +$3.93M 0.12% 165
2026
Q1
$27.9M Buy
+1,165,358
New +$28.5M 0.06% 169
2024
Q4
Sell
-334,529
Closed -$4.91M 1314
2024
Q3
$4.91M Sell
334,529
-327,805
-49% -$4.57M 0.04% 370
2024
Q2
$9.56M Buy
662,334
+267,080
+68% +$4.27M 0.08% 215
2024
Q1
$6.43M Sell
395,254
-11,915
-3% -$186K 0.07% 259
2023
Q4
$6.07M Buy
+407,169
New +$4.61M 0.07% 270
2023
Q3
Sell
-42,678
Closed -$429K 962
2023
Q2
$429K Buy
+42,678
New +$396K ﹤0.01% 509
2021
Q1
Sell
-162,500
Closed -$4.98M 984
2020
Q4
$4.98M Buy
+162,500
New +$4.96M 0.08% 103
2020
Q3
Sell
-400,792
Closed -$8.6M 507
2020
Q2
$8.6M Buy
400,792
+21,493
+6% +$475K 0.21% 73
2020
Q1
$8.57M Buy
+379,299
New +$10.4M 0.4% 58

Other funds holding ELAN

LMR Partners's ELAN Position: Q2 2026 in Review

LMR Partners increased its Elanco Animal Health (ELAN) stake by 15% in Q2 2026, buying an estimated $3.93M and bringing the position to 1,335,436 shares worth $32.9M. The position accounts for 0.12% of the portfolio, ranked #165.

LMR Partners first reported a position in ELAN in Q1 2020 and has held it in 10 quarters since. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • LMR Partners held 1,335,436 shares of Elanco Animal Health worth $32.9M as of Q2 2026.
  • LMR Partners bought 170,078 Elanco Animal Health shares in Q2 2026, an estimated $3.93M.
  • Elanco Animal Health made up 0.12% of LMR Partners's portfolio in Q2 2026, its #165 holding.
  • LMR Partners first reported a position in Elanco Animal Health in Q1 2020 and has held it in 10 quarters since.
  • 523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.